Cytogen, Inc. (KOSDAQ:217330)
South Korea · Delayed Price · Currency is KRW 3,150.00
-200.00 (-5.97%)
At close: Jun 30, 2026
Cytogen Market Cap
Cytogen has a market cap or net worth of 72.67 billion as of July 1, 2026. Its market cap has decreased by -16.00% in one year.
Market Cap
72.67B
Enterprise Value
63.51B
Revenue
26.84B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,150.00
Market Cap Chart
Since November 22, 2018, Cytogen's market cap has decreased from 87.89B to 72.67B, a decrease of -17.32%. That is a compound annual growth rate of -2.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 72.67B | -64.96% |
| Dec 30, 2025 | 207.40B | 98.24% |
| Dec 30, 2024 | 104.62B | -59.34% |
| Dec 28, 2023 | 257.28B | -11.12% |
| Dec 29, 2022 | 289.47B | -18.62% |
| Dec 30, 2021 | 355.72B | 47.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 224.42B |
| 3billion | 203.66B |
| GENINUS | 90.41B |
| Inventera | 74.96B |
| GC Medical Science | 67.07B |
| HLB Panagene | 66.47B |
| Protia | 50.49B |
| Seoulin Bioscience | 39.60B |